X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
index medicus (9) 9
middle aged (7) 7
female (6) 6
male (6) 6
abridged index medicus (5) 5
adult (4) 4
aged (4) 4
internal medicine (4) 4
medicine, general & internal (4) 4
time factors (4) 4
acute coronary syndromes (3) 3
analysis (3) 3
drug therapy (3) 3
france - epidemiology (3) 3
human health and pathology (3) 3
life sciences (3) 3
patient outcomes (3) 3
patients (3) 3
pharmacology (3) 3
prospective studies (3) 3
studies (3) 3
treatment outcome (3) 3
acute coronary syndrome - drug therapy (2) 2
blood platelets (2) 2
cancer (2) 2
cardiovascular disease (2) 2
care and treatment (2) 2
clinical trials (2) 2
clopidogrel (2) 2
colitis, ulcerative - epidemiology (2) 2
colorectal cancer (2) 2
diagnosis (2) 2
dosage and administration (2) 2
drugs (2) 2
hépatology and gastroenterology (2) 2
immunosuppressive agents - adverse effects (2) 2
management (2) 2
medical research (2) 2
medicine, experimental (2) 2
necrosis-factor-alpha (2) 2
of-function polymorphism (2) 2
percutaneous coronary intervention (2) 2
pharmacodynamics (2) 2
pharmacogenetics (2) 2
prognosis (2) 2
risk factors (2) 2
stent thrombosis (2) 2
thrombosis (2) 2
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[ sdv.imm.imm ] life sciences [q-bio]/immunology/immunotherapy (1) 1
[ sdv.mhep.chi ] life sciences [q-bio]/human health and pathology/surgery (1) 1
[ sdv.mhep.heg ] life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (1) 1
[ sdv.mhep.un ] life sciences [q-bio]/human health and pathology/urology and nephrology (1) 1
active metabolite (1) 1
acute coronary syndrome - diagnosis (1) 1
acute coronary syndrome - genetics (1) 1
acute coronary syndrome - mortality (1) 1
adenosine (1) 1
adenosine diphosphate (1) 1
adipokines - blood (1) 1
adiponectin expression (1) 1
adipose tissue - pathology (1) 1
adipose-tissue (1) 1
adjuvant treatment (1) 1
administration, oral (1) 1
adults (1) 1
age distribution (1) 1
angioplasty, balloon, coronary (1) 1
anticoagulants (1) 1
anticoagulants - administration & dosage (1) 1
anticoagulants - pharmacology (1) 1
antiplatelet therapy (1) 1
antiretroviral therapy (1) 1
artificial respiration (1) 1
aryl hydrocarbon hydroxylases - genetics (1) 1
aspirin (1) 1
atp binding cassette transporter, sub-family b (1) 1
atp-binding cassette, sub-family b, member 1 - genetics (1) 1
autoantibodies - blood (1) 1
autoimmune-diseases (1) 1
azathioprine (1) 1
b-lymphocyte subsets - drug effects (1) 1
b-lymphocyte subsets - immunology (1) 1
b-lymphocyte subsets - metabolism (1) 1
bioavailability (1) 1
biomarkers - blood (1) 1
blood clot (1) 1
blood clots (1) 1
blood coagulation - drug effects (1) 1
blood platelets - drug effects (1) 1
body mass index (1) 1
bowel disease (1) 1
cancer research (1) 1
cardiac & cardiovascular systems (1) 1
cardiovascular diseases (1) 1
cardiovascular diseases - etiology (1) 1
cardiovascular events (1) 1
cd4 lymphocyte count (1) 1
cd56 antigen - blood (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9701, pp. 1617 - 1625
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9749, pp. 1312 - 1319
Summary Background Clopidogrel and prasugrel are subject to efflux via P-glycoprotein (encoded by ABCB1 , also known as MDR1 ). ABCB1 polymorphisms,... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEALTHY JAPANESE SUBJECTS | RESPONSIVENESS | STENT THROMBOSIS | DUODENAL ENTEROCYTES | OF-FUNCTION POLYMORPHISM | PLATELET INHIBITION | MDR1 GENE | EXPRESSION | P-GLYCOPROTEIN | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Thiophenes - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Male | Angioplasty, Balloon, Coronary | Genetic Variation | Ticlopidine - adverse effects | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Cardiovascular Diseases - etiology | Pharmacogenetics | Genotype | Piperazines - therapeutic use | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Randomized Controlled Trials as Topic | Acute Coronary Syndrome - drug therapy | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Cytochrome P-450 CYP2C19 | ATP Binding Cassette Transporter, Sub-Family B | Polymorphism, Single Nucleotide | Acute Coronary Syndrome - genetics | Physiological aspects | Clopidogrel | Dosage and administration | Cardiovascular diseases | Drug therapy | Patient outcomes | Studies | Fees & charges | Heart attacks | Stock options | Acute coronary syndromes | Mass spectrometry | Drugs | Pharmacodynamics | Clinical trials | P-Glycoprotein | Pharmacokinetics | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9702, pp. 1687 - 1693
Journal Article
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 06/2019, Volume 75, Issue 6, pp. 743 - 750
Clinical pharmacology as a scientific discipline and medical specialty was unarguably born in the twentieth century. Whilst pharmacology-the science behind the... 
Clinical pharmacology | History | Committee membership | Pharmacology | Therapeutics | Homeopathy | Materia medica and therapeutics | Histamine | Medical treatment | Evolution | Occupational health | Drug discovery | Chemical compounds | Schools | Summer schools | Medieval period
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 07/2017, Volume 92, Issue 1, pp. 227 - 237
Primary membranous nephropathy (PMN) is characterized by antibodies to the podocyte, but little is known about B- and T-cell populations and their response to... 
regulatory T cells | natural killer cells | TNF-α | memory B cells | membranous nephropathy | rituximab | GLOMERULONEPHRITIS | SYSTEMIC-LUPUS-ERYTHEMATOSUS | PRIMARY SJOGRENS-SYNDROME | TNF-alpha | LYMPHOCYTE | HELPER-CELLS | NECROSIS-FACTOR-ALPHA | THERAPY | AUTOIMMUNE-DISEASES | UROLOGY & NEPHROLOGY | THROMBOCYTOPENIC PURPURA | NEPHROTIC SYNDROME | Predictive Value of Tests | T-Lymphocytes, Regulatory - metabolism | CD56 Antigen - blood | Glomerulonephritis, Membranous - blood | Autoantibodies - blood | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Tumor Necrosis Factor-alpha - blood | Male | T-Lymphocytes, Regulatory - immunology | Rituximab - therapeutic use | Time Factors | Glomerulonephritis, Membranous - immunology | Killer Cells, Natural - immunology | Adult | B-Lymphocyte Subsets - immunology | Female | Rituximab - adverse effects | Severity of Illness Index | B-Lymphocyte Subsets - drug effects | Receptors, IgG - blood | Interleukin-2 Receptor alpha Subunit - blood | Immunophenotyping | Treatment Outcome | CD4 Lymphocyte Count | Biomarkers - blood | Interleukin-5 - blood | Phenotype | T-Lymphocytes, Regulatory - drug effects | B-Lymphocyte Subsets - metabolism | Glomerulonephritis, Membranous - drug therapy | Glomerulonephritis, Membranous - diagnosis | GPI-Linked Proteins - blood | Immunosuppressive Agents - adverse effects | Aged | Killer Cells, Natural - drug effects | Killer Cells, Natural - metabolism | Paris | Index Medicus | Life Sciences | Human health and pathology | Immunology | Urology and Nephrology | Immunotherapy
Journal Article